Convergent Dental and Patterson Dental strengthen partnership through exclusive distribution of the Solea® All-Tissue Laser across North America
Exclusive distribution partnership will accelerate the broad-based adoption of Solea.
Waltham, MA — Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, announced today that the company has entered into an agreement with Patterson Dental, a subsidiary of Patterson Companies (Nasdaq: PDCO), that will make Patterson the exclusive North American distributor of the Solea laser.
“Convergent and Patterson have successfully partnered since 2016, and we are thrilled to take our business relationship to a new level,” said Robert L. Gershon, CEO of Convergent Dental. “This exclusive distribution agreement will help focus our go-to-market strategy and further optimize our partnership as we collectively drive the broad-based adoption of Solea.”
“Patterson has a proven track record of driving widespread adoption of leading technologies like Solea,” said Tim Rogan, President of Patterson Dental. “We are committed to bringing our customers the best possible practice solutions, and Solea undoubtedly aligns with that goal by empowering dentists to achieve better clinical and business outcomes.”
Solea is a novel 9.3-micron CO2 laser that allows for anesthesia-free, blood-free, and pain-free procedures in hard and soft tissue.1 It enables dentists to elevate and grow their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.2
1 Based on report of 1000 procedures performed by Solea users. Documentation on file.
2 Based on 2022 Annual Survey of Solea users. Documentation on file.